A recent head-to-head clinical trial comparing Wegovy and Zepbound returned similar results
These data included two large cardiovascular outcomes trials, one with saxagliptin and one with alogliptin
Industry analysts estimate that small-molecule production costs could be 10 to 100 times lower than peptide biologics, a differential that could fundamentally alter the health economics of GLP-1 therapy and expand access to hundreds of millions of patients worldwide who currently cannot afford or access injectable treatments
The Wegovy label carries a boxed warning on thyroid C-cell tumors observed in rodents, with human relevance undetermined, and contraindicates use in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
Samyaka says: Amazing and effective results
Injectable semaglutide (Ozempic, Wegovy) The injectable forms deliver semaglutide directly into the bloodstream via subcutaneous injection